Search research articles
Contact Us
Filters
Showing results (281-290 of 331) with videos related to
Page
of 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2023
Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial
Jeff M Michalski, Kathryn A Winter, Bradley R Prestidge, et al.
JAMA Oncology
|
January 27, 2018
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features
William L Hwang, Rahul D Tendulkar, Andrzej Niemierko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2007
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
Andrew J Stephenson, Peter T Scardino, Michael W Kattan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 3, 2023
Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415
Jinbing Bai, Stephanie L Pugh, Ronald Eldridge, et al.
European Urology
|
January 29, 2023
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial
Loren K Mell, Stephanie L Pugh, Christopher U Jones, et al.
Radiology
|
August 20, 2024
Quantitative <sup>68</sup>Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following <sup>177</sup>Lu-PSMA-617 (VISION Trial)
Phillip H Kuo, Michael J Morris, Jacob Hesterman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 13, 2019
Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial
Seth A Rosenthal, Chen Hu, Oliver Sartor, et al.
Brachytherapy
|
February 8, 2007
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States
Steven J Frank, Peter D Grimm, John E Sylvester, et al.
JAMA
|
September 22, 2011
Prediction of erectile function following treatment for prostate cancer
Mehrdad Alemozaffar, Meredith M Regan, Matthew R Cooperberg, et al.
Clinical Genitourinary Cancer
|
November 14, 2020
Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy
Benjamin W Fischer-Valuck, Jeff M Michalski, Joanna G Harton, et al.
Page
of 34
Search research articles
Search
Showing results (281-290 of 331) with videos related to
Sort By:
Page
of 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2023
Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial
Jeff M Michalski, Kathryn A Winter, Bradley R Prestidge, et al.
JAMA Oncology
|
January 27, 2018
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features
William L Hwang, Rahul D Tendulkar, Andrzej Niemierko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2007
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
Andrew J Stephenson, Peter T Scardino, Michael W Kattan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 3, 2023
Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415
Jinbing Bai, Stephanie L Pugh, Ronald Eldridge, et al.
European Urology
|
January 29, 2023
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial
Loren K Mell, Stephanie L Pugh, Christopher U Jones, et al.
Radiology
|
August 20, 2024
Quantitative <sup>68</sup>Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following <sup>177</sup>Lu-PSMA-617 (VISION Trial)
Phillip H Kuo, Michael J Morris, Jacob Hesterman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 13, 2019
Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial
Seth A Rosenthal, Chen Hu, Oliver Sartor, et al.
Brachytherapy
|
February 8, 2007
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States
Steven J Frank, Peter D Grimm, John E Sylvester, et al.
JAMA
|
September 22, 2011
Prediction of erectile function following treatment for prostate cancer
Mehrdad Alemozaffar, Meredith M Regan, Matthew R Cooperberg, et al.
Clinical Genitourinary Cancer
|
November 14, 2020
Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy
Benjamin W Fischer-Valuck, Jeff M Michalski, Joanna G Harton, et al.
Page
of 34